Trial · NCT00184054
Adverse events17
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 17 of 17
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anorexia | Metabolism and nutrition disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 2 | 11 | 4 |
| other | Cellulitis - hand | Infections and infestations | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 1 |
| other | Localized edema | General disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 2 | 11 | 2 |
| other | Electrocardiogram QT corrected interval prolonged | Investigations | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 1 |
| other | Fatigue | General disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 3 | 11 | 3 |
| other | Headache | Nervous system disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 5 | 11 | 8 |
| other | Nausea | Gastrointestinal disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 5 | 11 | 10 |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 2 | 11 | 2 |
| other | Urinary Tract Infection | Infections and infestations | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 1 |
| other | Vomiting | Gastrointestinal disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 5 | 11 | 10 |
| serious | Anorexia | Metabolism and nutrition disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 2 |
| serious | Alanine aminotransferase increased | Investigations | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 1 |
| serious | Conjunctivitis infective | Infections and infestations | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 2 | 11 | 2 |
| serious | Differentiation syndrome | General disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 1 |
| serious | Electrocardiogram QT corrected interval prolonged | Investigations | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 1 |
| serious | Neuropathy sensory | Nervous system disorders | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 1 | 11 | 1 |
| serious | Sepsis | Infections and infestations | Arsenic Trioxide (ATO) Plus Ascorbic Acid | 4 | 11 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00184054/events